Delivery Order SPE2DB22D2206-SPE2DB24FEJ31
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,851.68, is for the delivery of GAMUNEX-C 40 gram/400 ml vials. This is a firm fixed-price delivery order contract with a period of performance ending on January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,852.80 firm-fixed-price delivery order contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, with a period of performance through June 30, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,925.84 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $9,308.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with an ultimate completion date of July 24, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,908.00, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,157.05, is a delivery order for the product "GAMUNEX-C 10 GRAM/100 ML VIAL 100ML" and has a period of performance through April 25, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,876.40, is a Firm Fixed Price Delivery Order for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a ceiling value of $17,702.10. It is a firm-fixed-price delivery order contract, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The $11,912.50 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $49,752.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, with a performance period through December 6, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEJ31Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,315.12, is for the delivery of GAMUNEX-C 40 gram/400 ML vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2023. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 11/28/23 |